Clinical Trial Update: "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat [Phase 2]

View source ↗

Summary

Phase 2 trial in obesity completed, showing Pecos—a B-adrenergic and PPAR-G stimulator—upregulates lipid metabolism in human subcutaneous fat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Pecos

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Obesity | Phase 2 | Status: COMPLETED